Sign In
Buy EBS
$7.93
-0.280 (-3.41%)
At Close: Jun 03, 2026
Novavax soars after U.S. government awards firm $1.6 billion for coronavirus vaccine development
10:12am, Tuesday, 07'th Jul 2020
The U.S. government has awarded Novavax $1.6 billion to cover testing, commercialization and manufacturing of a potential coronavirus vaccine in the United States, with the aim of delivering 100 milli
U.S. government awards Novavax $1.6 billion for coronavirus vaccine
10:00am, Tuesday, 07'th Jul 2020
The U.S. government has awarded Novavax Inc $1.6 billion to cover testing, commercialization and manufacturing of a potential coronavirus vaccine in the United States, with the aim of delivering 100 m
U.S. government awards Novavax $1.6 billion for coronavirus vaccine
12:00am, Tuesday, 07'th Jul 2020
U.S. government awards Novavax $1.6 billion for coronavirus vaccine
Coronavirus update: U.S. cases reach 2.9 million and death toll tops 130K, as 38 states see cases on the climb
06:02pm, Monday, 06'th Jul 2020
New coronavirus cases continue to surge Monday, with the U.S. re-emerging as a global hot spot, while Wall Street continues to defy the dangers after...
Emergent BioSolutions inks coronavirus vaccine manufacturing deal with J&J
11:56am, Monday, 06'th Jul 2020
Shares of Emergent BioSolutions Inc. were up 1.1% in premarket trading on Monday after it announced a five-year deal with Johnson & Johnson to manufacture the drug substance for the drugmaker's stil
Emergent signs five-year deal backing J&J COVID-19 vaccine
10:52am, Monday, 06'th Jul 2020
Under the deal, starting next year Emergent will provide large-scale manufacturing services to produce the drug substance over five years, with the first two years valued at about $480 million. The n
Emergent to make drug substance for J&J's COVID-19 vaccine candidate
10:51am, Monday, 06'th Jul 2020
Emergent BioSolutions Inc. (EBS) today announced a five-year manufacturing services agreement with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, for
Emergent Biosolutions (NYSE:EBS) PT Raised to $93.00 at Wells Fargo & Co
04:54am, Monday, 06'th Jul 2020
Emergent Biosolutions (NYSE:EBS) had its target price increased by Wells Fargo & Co from $85.00 to $93.00 in a research note published on Thursday morning, The Fly reports. The firm currently has an o
Better Coronavirus Stock: Emergent Biosolutions vs. Regeneron | The Motley Fool
10:27am, Sunday, 05'th Jul 2020
Both of these companies could play a huge role in ending the COVID-19 pandemic.
Why Emergent BioSolutions Stock Soared 47% in the First Half of 2020
02:25pm, Saturday, 04'th Jul 2020
This biotech has emerged as the manufacturing partner of choice for companies developing COVID-19 vaccines.
Emergent Biosolutions Inc (NYSE:EBS) Shares Purchased by Jane Street Group LLC
08:00am, Saturday, 04'th Jul 2020
Jane Street Group LLC raised its stake in Emergent Biosolutions Inc (NYSE:EBS) by 8.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SE
5 Booming Biotech Stocks to Buy
04:36pm, Friday, 03'rd Jul 2020
These five biotech stocks have already gone on heaters of 30% or more in 2020, and all of them still have plenty of upside to spare.
These 3 Things Could Send Novavax's Stock Soaring to New Heights | The Motley Fool
03:21pm, Thursday, 02'nd Jul 2020
Here's why the company's amazing run on the stock market year to date could continue.
Amgen (AMGN) Looks Good: Stock Adds 8.2% in Session
12:55pm, Thursday, 02'nd Jul 2020
Amgen (AMGN) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
